BSE : 78788
NSE : REMUS
Sector :Health care
ISIN Code : INE0O5T01011
NSE
2487.10
34.75 (1.42%)
BSE
(%)
Remus Pharmaceuticals Limited for the quarter ended 30-Sep-2024 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company was required to clarify the following: -1. Financial results submitted is not as per format prescribed by SEBI The response of the Company is enclosed.